Single Patient Study to Evaluate Cellular Adoptive Immunotherapy Using Autologous Lymphocytes Following Cyclophosphamide Conditioning for a Single Patient With Metastatic Melanoma.

Status: Completed

Phase of Trial: Phase I/II

Latest Information Update: 07 Apr 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Tumour infiltrating lymphocytes (Primary) ; Aldesleukin; Cyclophosphamide
Indications Malignant melanoma
Focus Adverse reactions; Expanded access; Therapeutic Use

14 May 2010 Planned end date changed from 1 Jun 2010 to 1 Apr 2010 as reported by ClinicalTrials.gov.
12 May 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
09 Nov 2009 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com